Clover Biopharmaceuticals is a biopharmaceutical company based in China that works on vaccines and biologic medicines. It develops protein-based vaccine candidates and therapeutic biologics, using its own technology platforms to design products aimed at infectious diseases and other serious conditions. Its work serves public health and clinical markets, with development programmes that include vaccine candidates for respiratory infections. The company carries out research and development and partners with other organisations on clinical studies and manufacturing.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 2197, and the price on this page is in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1852 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendWeak
28/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-38.6%
From 52-week high-57.3%
MomentumWeak
33/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-16.8%
6-month return-56.9%
12-month, skipping last month-1.0%
Stability (higher is calmer)Weak
29/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)81.0%
Worst drawdown, 1 year (smaller is calmer)-58.0%
LiquidityStrong
74/100
Trades actively.
See the numbers →
Avg daily value traded8.22M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 1.300 – 3.200Daily closes, split-adjusted
Signals
50-day average1.998
200-day average2.182
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.132
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
1.59
Bearish
EMA 10
1.57
Bearish
SMA 20
1.76
Bearish
EMA 20
1.70
Bearish
SMA 50
2.00
Bearish
EMA 50
1.87
Bearish
SMA 100
1.87
Bearish
EMA 100
1.97
Bearish
SMA 200
2.18
Bearish
EMA 200
1.98
Bearish
Oscillators (daily)
RSI (14)
22.66
Bullish
MACD (12, 26)
-0.15
Bearish
Momentum (12)
-27.17
Bearish
Stochastic %K (14)
6.45
Bullish
Williams %R (14)
-93.55
Bullish
CCI (20)
-156.1
Bullish
Pivot points (classic, last session)
S3
1.06
S2
1.18
S1
1.26
Pivot
1.38
R1
1.46
R2
1.58
R3
1.66
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
